Marshall & Sterling Wealth Advisors Inc.
Source: SEC Form 13F · as of Mar 2026Marshall & Sterling Wealth Advisors Inc. holds 21 biotech & pharma companies tracked by BioSniper, totaling $1.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$1.8M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 1,894 | $667K |
| MCKMcKesson Corporation | 508 | $440K |
| ABBVAbbVie Inc. | 1,627 | $354K |
| NVSNovartis AG | 515 | $79K |
| MRKMerck & Co., Inc. | 460 | $55K |
| ABTABBOTT LABORATORIES | 499 | $51K |
| SUNSUNSET ISLAND GROUP | 602 | $39K |
| LLYELI LILLY & Co | 40 | $37K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 51 | $14K |
| GEHCGE HealthCare Technologies Inc. | 184 | $13K |
| GILDGILEAD SCIENCES, INC. | 71 | $10K |
| PFEPFIZER INC | 331 | $9K |
| NVONovo Nordisk A/S | 218 | $8K |
| JNJJOHNSON & JOHNSON | 31 | $8K |
| TECXTectonic Therapeutic, Inc. | 50 | $2K |
| CMPXCompass Therapeutics, Inc. | 200 | $1K |
| FDMT4D Molecular Therapeutics, Inc. | 100 | $931 |
| IBRXImmunityBio, Inc. | 50 | $384 |
| VERUVERU INC. | 95 | $210 |
| CGCCanopy Growth Corp | 154 | $147 |
| ACBAURORA CANNABIS INC | 1 | $3 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.